Surufatinib in US patients with soft tissue sarcoma.

Movva, S; Spira, AI; Hamilton, EP; Wang, JS; Cohn, AL; Strauss, JF; Stacchiotti, S; Tucci, C; Kauh, J; Nanda, S; Kania, MK; Patel, S

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):